PJAK2 (1001–1013)
Product Specifications
CAS Number
1259928-08-9
Target
JAK
Related Pathways
Tyrosine Kinase/Adaptors, JAK/STAT signaling, Stem Cells, Angiogenesis, Chromatin/Epigenetic
Bioactivity
PJAK2 (1001–1013) acts as a SOCS1/3 antagonist, enhancing the JAK/STAT signaling pathway by inhibiting the negative regulatory effects of SOCS proteins, thereby playing a crucial role in antiviral immune responses.
Smiles
C([C@H](CC(C)C)N)(=O)N1[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@@H](CC2=CC=C(OP(=O)(O)O)C=C2)C(N[C@@H](CC3=CC=C(O)C=C3)C(N[C@H](C(N[C@H](C(N[C@H](C(N[C@H](C(=O)N4[C@H](C(O)=O)CCC4)CCC(O)=O)=O)CCCCN)=O)C(C)C)=O)CCCCN)=O)=O)=O)CCC(O)=O)=O)CCCCN)=O)CC(O)=O)=O)CCC(N)=O)=O)CCC1
Molecular Formula
C76H118N17O26P
Molecular Weight
1716.82
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
GTR15121331 1 Vial
Lentiviral human SLC6A9 shRNA (UAS) - Lentiviral human SLC6A9 shRNA (UAS, RFP) (25)
Sign In for Pricing
View Details 